Data › Companies › AIRS

Airsculpt Technologies, Inc. (AIRS)

Nasdaq · Services-Offices & Clinics Of Doctors Of Medicine · Services · CIK 1870940 · fiscal year ends in Dec

Closing price $1.72 on 30 Oct 2026; 52-week range $1.18 to $10.58.

Key figures

The last twelve months reported, with the latest price and balance sheet.

Revenue, last twelve months
$150.7M
Revenue growth
-8.7%
Net income, last twelve months
-$11.7M
Earnings per share
-$0.18
Gross margin
59.7%
Operating margin
-8.4%
Net margin
-7.8%
Free cash flow
$760.0K
Return on equity
-11.2%
Market value
$123.0M
Cash
$18.8M
Debt
$43.6M
Debt to equity
0.42
Shares outstanding
71.5M

Financial statements

Revenue, profit and cash flow by fiscal year, each year linked to its annual report.

Fiscal yearYear endRevenueOperating incomeNet incomeEPSFree cash flowFiling
FY202531 Dec 2025$151.8M-$11.6M-$11.7M-$0.19$692.0K10-K filed 31 Mar 2026
FY202431 Dec 2024$180.3M-$1.6M-$8.0M-$0.14-$2.7M10-K filed 14 Mar 2025
FY202331 Dec 2023$195.9M$9.7M-$4.2M-$0.08$14.0M10-K filed 27 Feb 2024
FY202231 Dec 2022$168.8M-$4.5M-$14.7M-$0.26$11.5M10-K filed 10 Mar 2023
FY202131 Dec 2021$133.3M$15.8M$10.6M-$0.01$19.5M10-K filed 11 Mar 2022

By quarter

QuarterQuarter endRevenueNet incomeEPS
Q2 FY202630 Jun 2026$42.9M-$1.1M-$0.02
Q1 FY202631 Mar 2026$39.4M-$2.4M-$0.03
Q4 FY202531 Dec 2025$33.4M$1.3M$0.02
Q3 FY202530 Sep 2025$35.0M-$9.5M-$0.15
Q2 FY202530 Jun 2025$44.0M-$591.0K-$0.01
Q1 FY202531 Mar 2025$39.4M-$2.8M-$0.05
Q4 FY202431 Dec 2024$39.2M-$5.0M-$0.09
Q3 FY202430 Sep 2024$42.5M-$6.0M-$0.10

Company events

The newest 8-K filings of 47 held.

FiledFormEventItems
12 Aug 20268-KOther events8.01, 9.01
10 Aug 20268-KResults2.02, 9.01
14 May 20268-KShareholder vote5.07
8 May 20268-KResults2.02, 9.01
6 Apr 20268-K/AResults2.02, 9.01
2 Apr 20268-KResults2.02, 9.01
16 Mar 20268-KResults2.02, 9.01
18 Nov 20258-KLeadership change5.02, 9.01
7 Nov 20258-KResults, Leadership change2.02, 5.02, 9.01
5 Nov 20258-KLeadership change5.02, 9.01
1 Aug 20258-KLeadership change5.02, 9.01
1 Aug 20258-KResults, Leadership change2.02, 5.02, 9.01

Every filing

The newest filings with the SEC of 119 held.

FiledFormPeriod
12 Aug 20268-K5 Aug 2026
10 Aug 202610-Q30 Jun 2026
10 Aug 20268-K10 Aug 2026
14 May 20268-K12 May 2026
8 May 202610-Q31 Mar 2026
8 May 20268-K8 May 2026
16 Apr 2026ARS31 Dec 2025
15 Apr 2026DEF 14A12 May 2026
6 Apr 20268-K/A2 Apr 2026
6 Apr 202610-K/A31 Dec 2025
2 Apr 20268-K2 Apr 2026
31 Mar 202610-K31 Dec 2025

Insider trades

Form 4 trades by officers, directors and 10% owners, last 12 months.

TradedInsiderTypeSharesPriceValueHeld afterForm 4
17 Apr 2026Chernett Jorey, 10% ownerPurchase40,000$2.54$101.6K7,053,76120 Apr 2026
14 Apr 2026Chernett Jorey, 10% ownerPurchase20,000$2.60$52.0K7,013,76115 Apr 2026
7 Apr 2026Chernett Jorey, 10% ownerPurchase60,000$2.93$175.8K6,993,7618 Apr 2026
3 Apr 2026Chernett Jorey, 10% ownerPurchase90,000$2.82$253.8K6,933,7616 Apr 2026
23 Mar 2026Chernett Jorey, 10% ownerPurchase50,000$2.91$145.5K6,843,76125 Mar 2026
20 Mar 2026Chernett Jorey, 10% ownerPurchase40,000$2.77$110.8K6,793,76123 Mar 2026
19 Mar 2026Chernett Jorey, 10% ownerPurchase77,702$2.64$205.1K6,753,76120 Mar 2026
17 Mar 2026Chernett Jorey, 10% ownerPurchase83,000$2.56$212.5K6,676,05918 Mar 2026
16 Mar 2026Chernett Jorey, 10% ownerPurchase105,848$2.43$257.2K6,592,05916 Mar 2026
11 Mar 2026Chernett Jorey, 10% ownerPurchase88,000$2.15$189.2K6,486,21111 Mar 2026
6 Mar 2026Chernett Jorey, 10% ownerPurchase45,600$2.00$91.2K6,398,2119 Mar 2026
4 Mar 2026Chernett Jorey, 10% ownerPurchase30,000$1.87$56.1K6,352,6114 Mar 2026

Large holders

Schedule 13D and 13G filings by holders of more than 5% of the voting shares.

FiledHolderScheduleStakeShares
28 Oct 2026THRIVENT FINANCIAL FOR LUTHERANS13G amended4.98%3.6M
12 Aug 2026EBS Aggregator Blocker Holdings, LLC13G amended42.1%30.3M
10 Aug 2026THRIVENT FINANCIAL FOR LUTHERANS13G amended6.3%4.4M
1 Jun 2026Rollins Aaron13G20.9%14.7M
21 Apr 2026Parian Ultreia LP13G amended9.6%6.7M
16 Mar 2026Parian Ultreia LP13G amended9.6%6.0M
13 Mar 2026Rollins Aaron13D23.6%14.7M
4 Mar 2026Chernett Jorey13G amended10.79%6.8M
17 Feb 2026Parian Ultreia LP13G5.1%3.2M
13 Feb 2026SW Investment Management LLC13G amended0%0

Short interest

Shares sold short and not yet bought back, on each FINRA settlement date.

SettlementShares shortChangeDays to cover
15 Oct 20263.0M-1.73%3.45
30 Sep 20263.0M-2.12%3.33
15 Sep 20263.1M+2.12%3.22
31 Aug 20263.0M+7.58%3.58
14 Aug 20262.8M+1.11%2.29
31 Jul 20262.8M-10.61%6.89
15 Jul 20263.1M-8.55%7.83
30 Jun 20263.4M-1.96%5.81

Funds that hold it

From each fund's latest Form 13F.

112 funds held it at 30 Jun 2026: 61 added and 27 trimmed in the quarter. The largest:

FundSharesValueChange in the quarter
Vesey Street Capital Partners, L.L.C.30,324,180$136.5M0
Thrivent Financial for Lutherans4,425,000$19.9M+4,425,000
BlackRock, Inc.1,278,871$5.8M+474,792
Wexford Capital LP841,734$3.8M+171,217
UBS Group AG792,183$3.6M+169,891
FourWorld Capital Management LLC750,000$3.4M-237,757
Flputnam Investment Management Co.691,989$3.1M+691,989
AQR Capital Management LLC470,723$2.1M+161,394
Geode Capital Management, LLC451,224$2.0M+82,768
Gsa Capital Partners LLP425,186$1.9M+167,837

Peers

Companies in the same industry.

  • Hims & Hers Health, Inc. (HIMS): revenue $2.6B, market value $6.5B
  • Teladoc Health, Inc. (TDOC): revenue $2.5B, market value $1.6B
  • Starling Oncology, Inc. (STLN): revenue $587.2M, market value $655.6M
  • SBC Medical Group Holdings Inc. (SBC): revenue $175.2M, market value $541.1M
  • LifeMD, Inc. (LFMD): revenue –, market value $110.0M
Services · Nasdaq companies · Every company we cover